Après votre arrêt cardiaque, vous prendrez bien un peu d'élixir de (sur)vie [After your heart arrest, would you like to test a medicinal elixir?].


Autoria(s): Carron P.N.; Hugli O.; Liaudet L.; Yersin B.
Data(s)

2005

Resumo

So far, cardiac arrest is still associated with high mortality or severe neurological disability in survivors. At the tissue level, cardiac arrest results into an acute condition of generalized hypoxia. A better understanding of the pathophysiology of ischemia-reperfusion and of the inflammatory response that develops after cardiac arrest could help to design novel therapeutic strategies in the future. It seems unlikely that a single drug, acting as a <magic bullet>, might be able to improve survival or neurological prognosis. Lessons learned from pathophysiological mechanisms rather indicate that combined therapies, involving thrombolysis, neuroprotective agents, antioxidants and anti-inflammatory molecules, together with temperature cooling, might represent helpful strategies to improve patient's outcome after cardiac arrest.

Identificador

http://serval.unil.ch/?id=serval:BIB_74D0B2079E58

isbn:1660-9379 (Print)

pmid:15786650

Idioma(s)

fr

Fonte

Revue Médicale Suisse, vol. 1, no. 6, pp. 448-451

Palavras-Chave #Anti-Inflammatory Agents/therapeutic use; Antioxidants/therapeutic use; Fibrinolytic Agents/therapeutic use; Heart Arrest/prevention & control; Humans; Neuroprotective Agents/therapeutic use
Tipo

info:eu-repo/semantics/article

article